{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:50:05Z","timestamp":1772121005291,"version":"3.50.1"},"publisher-location":"Cham","reference-count":193,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783031358067","type":"print"},{"value":"9783031358074","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/82_2020_214","type":"book-chapter","created":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T12:05:06Z","timestamp":1590494706000},"page":"1-22","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["50\u00a0Years of Lassa Fever Research"],"prefix":"10.1007","author":[{"given":"Robert F.","family":"Garry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,27]]},"reference":[{"key":"214_CR1","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nsmb.1772","volume":"17","author":"J Abraham","year":"2010","unstructured":"Abraham J, Corbett KD, Farzan M, Choe H, Harrison SC (2010) Structural basis for receptor recognition by New World hemorrhagic fever arenaviruses. Nat Struct Mol Biol 17:438\u2013444. https:\/\/doi.org\/10.1038\/nsmb.1772","journal-title":"Nat Struct Mol Biol"},{"key":"214_CR2","doi-asserted-by":"crossref","unstructured":"Ahmed R, Salmi A, Butler LD, Chiller JM, Oldstone MB (1984) Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J Exp Med 160:521\u2013540","DOI":"10.1084\/jem.160.2.521"},{"key":"214_CR3","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.1038\/s41598-020-59880-w","volume":"10","author":"FV Ajogbasile","year":"2020","unstructured":"Ajogbasile FV et al (2020) Real-time metagenomic analysis of undiagnosed fever cases unveils a yellow fever outbreak in Edo State, Nigeria. Sci Rep 10:3180. https:\/\/doi.org\/10.1038\/s41598-020-59880-w","journal-title":"Sci Rep"},{"key":"214_CR4","doi-asserted-by":"publisher","first-page":"e0005711","DOI":"10.1371\/journal.pntd.0005711","volume":"11","author":"OC Akhuemokhan","year":"2017","unstructured":"Akhuemokhan OC et al (2017) Prevalence of lassa virus disease (LVD) in Nigerian children with fever or fever and convulsions in an endemic area. PLoS Negl Tropical Dis 11:e0005711. https:\/\/doi.org\/10.1371\/journal.pntd.0005711","journal-title":"PLoS Negl Tropical Dis"},{"key":"214_CR5","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.cell.2015.07.020","volume":"162","author":"KG Andersen","year":"2015","unstructured":"Andersen KG et al (2015) Clinical sequencing uncovers origins and evolution of Lassa virus. Cell 162:738\u2013750. https:\/\/doi.org\/10.1016\/j.cell.2015.07.020","journal-title":"Cell"},{"key":"214_CR6","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0035-9203(77)90085-2","volume":"71","author":"RB Arnold","year":"1977","unstructured":"Arnold RB, Gary GW (1977) A neutralization test survey for Lassa Fever activity in Lassa, Nigeria. Trans R Soc Trop Med Hyg 71:152\u2013154","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"214_CR7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0168-1702(88)90033-0","volume":"9","author":"DD Auperin","year":"1988","unstructured":"Auperin DD et al (1988) Construction of a recombinant vaccinia virus expressing the Lassa virus glycoprotein gene and protection of guinea pigs from a lethal Lassa virus infection. Virus Res 9:233\u2013248","journal-title":"Virus Res"},{"issue":"Pt 1","key":"214_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1099\/0022-1317-71-1-19","volume":"71","author":"GN Barber","year":"1990","unstructured":"Barber GN, Clegg JC, Lloyd G (1990) Expression of the Lassa virus nucleocapsid protein in insect cells infected with a recombinant baculovirus: application to diagnostic assays for Lassa virus infection. J Gen Virol 71(Pt 1):19\u201328. https:\/\/doi.org\/10.1099\/0022-1317-71-1-19","journal-title":"J Gen Virol"},{"key":"214_CR9","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1128\/JCM.38.7.2670-2677.2000","volume":"38","author":"DG Bausch","year":"2000","unstructured":"Bausch DG et al (2000) Diagnosis and clinical virology of Lassa fever as evaluated by enzyme-linked immunosorbent assay, indirect fluorescent-antibody test, and virus isolation. J Clin Microbiol 38:2670\u20132677","journal-title":"J Clin Microbiol"},{"key":"214_CR10","doi-asserted-by":"publisher","unstructured":"Bausch DG et al (2001) Lassa fever in Guinea: I. Epidemiology of human disease and clinical observations. Vector Borne Zoonotic Dis 1:269\u2013281. https:\/\/doi.org\/10.1089\/15303660160025903","DOI":"10.1089\/15303660160025903"},{"key":"214_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.antiviral.2014.09.001","volume":"111C","author":"DG Bausch","year":"2014","unstructured":"Bausch DG et al (2014) A tribute to Sheik Humarr Khan and all the healthcare workers in West Africa who have sacrificed in the fight against Ebola virus disease: Mae we hush. Antiviral Res 111C:33\u201335. https:\/\/doi.org\/10.1016\/j.antiviral.2014.09.001","journal-title":"Antiviral Res"},{"key":"214_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00103-019-03061-2","volume":"63","author":"V Bernasconi","year":"2020","unstructured":"Bernasconi V et al (2020) Developing vaccines against epidemic-prone emerging infectious diseases. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 63:65\u201373. https:\/\/doi.org\/10.1007\/s00103-019-03061-2","journal-title":"Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz"},{"key":"214_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw261","author":"ML Boisen","year":"2016","unstructured":"Boisen ML et al (2016) Field validation of the ReEBOV antigen rapid test for point-of-care diagnosis of Ebola virus infection. J Infect Dis. https:\/\/doi.org\/10.1093\/infdis\/jiw261","journal-title":"J Infect Dis"},{"key":"214_CR14","doi-asserted-by":"publisher","first-page":"5939","DOI":"10.1038\/s41598-018-24246-w","volume":"8","author":"ML Boisen","year":"2018","unstructured":"Boisen ML et al (2018) Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever. Sci Rep 8:5939. https:\/\/doi.org\/10.1038\/s41598-018-24246-w","journal-title":"Sci Rep"},{"key":"214_CR15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.4269\/ajtmh.2012.12-0466","volume":"88","author":"N Bond","year":"2013","unstructured":"Bond N, Schieffelin JS, Moses LM, Bennett AJ, Bausch DG (2013) A historical look at the first reported cases of Lassa fever: IgG antibodies 40\u00a0years after acute infection. Am J Trop Med Hyg 88:241\u2013244. https:\/\/doi.org\/10.4269\/ajtmh.2012.12-0466","journal-title":"Am J Trop Med Hyg"},{"key":"214_CR16","doi-asserted-by":"publisher","first-page":"6992","DOI":"10.1128\/jvi.74.15.6992-7004.2000","volume":"74","author":"MD Bowen","year":"2000","unstructured":"Bowen MD et al (2000) Genetic diversity among Lassa virus strains. J Virol 74:6992\u20137004. https:\/\/doi.org\/10.1128\/jvi.74.15.6992-7004.2000","journal-title":"J Virol"},{"key":"214_CR17","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1743-422x-5-74","volume":"5","author":"LM Branco","year":"2008","unstructured":"Branco LM et al (2008) Bacterial-based systems for expression and purification of recombinant Lassa virus proteins of immunological relevance. Virol J 5:74. https:\/\/doi.org\/10.1186\/1743-422x-5-74","journal-title":"Virol J"},{"key":"214_CR18","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/288486a0","volume":"288","author":"MJ Buchmeier","year":"1980","unstructured":"Buchmeier MJ, Lewicki HA, Tomori O, Johnson KM (1980) Monoclonal antibodies to lymphocytic choriomeningitis virus react with pathogenic arenaviruses. Nature 288:486\u2013487. https:\/\/doi.org\/10.1038\/288486a0","journal-title":"Nature"},{"key":"214_CR19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0042-6822(81)90137-9","volume":"113","author":"MJ Buchmeier","year":"1981","unstructured":"Buchmeier MJ, Lewicki HA, Tomori O, Oldstone MB (1981) Monoclonal antibodies to lymphocytic choriomeningitis and pichinde viruses: generation, characterization, and cross-reactivity with other arenaviruses. Virology 113:73\u201385. https:\/\/doi.org\/10.1016\/0042-6822(81)90137-9","journal-title":"Virology"},{"key":"214_CR20","doi-asserted-by":"crossref","unstructured":"Buckley SM, Casals J (1970) Lassa fever, a new virus disease of man from West Africa. 3. Isolation and characterization of the virus. Am J Trop Med Hyg 19:680\u2013691","DOI":"10.4269\/ajtmh.1970.19.680"},{"key":"214_CR21","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/227174a0","volume":"227","author":"SM Buckley","year":"1970","unstructured":"Buckley SM, Casals J, Downs WG (1970) Isolation and antigenic characterization of Lassa virus. Nature 227:174","journal-title":"Nature"},{"key":"214_CR22","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/s1473-3099(17)30062-2","volume":"17","author":"T Burki","year":"2017","unstructured":"Burki T (2017) CEPI: preparing for the worst. The Lancet. Infect Dis 17:265\u2013266. https:\/\/doi.org\/10.1016\/s1473-3099(17)30062-2","journal-title":"The Lancet. Infect Dis"},{"key":"214_CR23","unstructured":"Campbell G (2002) Blood diamond: tracing the deadly path of the world\u2019s most precious stones. Westview Press"},{"key":"214_CR24","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1126\/science.282.5396.2079","volume":"282","author":"W Cao","year":"1998","unstructured":"Cao W et al (1998) Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science 282:2079\u20132081. https:\/\/doi.org\/10.1126\/science.282.5396.2079","journal-title":"Science"},{"key":"214_CR25","doi-asserted-by":"crossref","unstructured":"Carey DE et al (1972) Lassa fever. Epidemiological aspects of the 1970 epidemic, Jos, Nigeria. Trans R Soc Trop Med Hyg 66:402\u2013408","DOI":"10.1016\/0035-9203(72)90271-4"},{"key":"214_CR26","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1080\/21645515.2017.1356500","volume":"13","author":"KA Cashman","year":"2017","unstructured":"Cashman KA et al (2017a) A DNA vaccine delivered by dermal electroporation fully protects cynomolgus macaques against Lassa fever. Human Vaccines Immunotherapeutics 13:2902\u20132911. https:\/\/doi.org\/10.1080\/21645515.2017.1356500","journal-title":"Human Vaccines Immunotherapeutics"},{"key":"214_CR27","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1080\/21645515.2017.1382780","volume":"13","author":"KA Cashman","year":"2017","unstructured":"Cashman KA et al (2017b) DNA vaccines elicit durable protective immunity against individual or simultaneous infections with Lassa and Ebola viruses in guinea pigs. Hum Vaccines Immunotherapeutics 13:3010\u20133019. https:\/\/doi.org\/10.1080\/21645515.2017.1382780","journal-title":"Hum Vaccines Immunotherapeutics"},{"key":"214_CR28","doi-asserted-by":"publisher","unstructured":"Cashman KA. et al (2018) Immune-mediated systemic vasculitis as the proposed cause of sudden-onset sensorineural hearing loss following Lassa virus exposure in cynomolgus macaques. mBio 9. https:\/\/doi.org\/10.1128\/mbio.01896-18","DOI":"10.1128\/mbio.01896-18"},{"key":"214_CR29","unstructured":"Chu M (2018). In: Barton HA, Whitaker RJ (eds). Ch. 31 Amer Soc Microbiol"},{"key":"214_CR30","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1099\/0022-1317-64-5-1127","volume":"64","author":"JC Clegg","year":"1983","unstructured":"Clegg JC, Lloyd G (1983) Structural and cell-associated proteins of Lassa virus. J Gen Virol 64:1127\u20131136. https:\/\/doi.org\/10.1099\/0022-1317-64-5-1127","journal-title":"J Gen Virol"},{"key":"214_CR31","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/s0140-6736(87)90767-7","volume":"2","author":"JC Clegg","year":"1987","unstructured":"Clegg JC, Lloyd G (1987) Vaccinia recombinant expressing Lassa-virus internal nucleocapsid protein protects guineapigs against Lassa fever. Lancet 2:186\u2013188. https:\/\/doi.org\/10.1016\/s0140-6736(87)90767-7","journal-title":"Lancet"},{"key":"214_CR32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF02122423","volume":"175","author":"JC Clegg","year":"1986","unstructured":"Clegg JC, Barber GN, Chamberlain JF, Oram JD (1986) Expression of Lassa virus nucleocapsid gene fragments in bacteria. Med Microbiol Immunol 175:93\u201395","journal-title":"Med Microbiol Immunol"},{"key":"214_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw293","author":"RW Cross","year":"2016","unstructured":"Cross RW et al (2016a) Analytical validation of the ReEBOV antigen rapid test for point-of-care diagnosis of Ebola virus infection. J Infect Dis. https:\/\/doi.org\/10.1093\/infdis\/jiw293","journal-title":"J Infect Dis"},{"key":"214_CR34","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.antiviral.2016.08.012","volume":"133","author":"RW Cross","year":"2016","unstructured":"Cross RW et al (2016b) Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies. Antiviral Res 133:218\u2013222. https:\/\/doi.org\/10.1016\/j.antiviral.2016.08.012","journal-title":"Antiviral Res"},{"key":"214_CR35","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.coviro.2019.07.003","volume":"37","author":"RW Cross","year":"2019","unstructured":"Cross RW et al (2019) Antibody therapy for Lassa fever. Curr Opin Virol 37:97\u2013104. https:\/\/doi.org\/10.1016\/j.coviro.2019.07.003","journal-title":"Curr Opin Virol"},{"key":"214_CR36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/004947559202200213","volume":"22","author":"D Cummins","year":"1992","unstructured":"Cummins D (1992) Rats, fever and sudden deafness in Sierra Leone. Trop Doct 22:83\u201384","journal-title":"Trop Doct"},{"key":"214_CR37","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1365-2141.1989.tb04321.x","volume":"72","author":"D Cummins","year":"1989","unstructured":"Cummins D et al (1989) A plasma inhibitor of platelet aggregation in patients with Lassa fever. Br J Haematol 72:543\u2013548","journal-title":"Br J Haematol"},{"key":"214_CR38","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1001\/jama.1990.03450160063030","volume":"264","author":"D Cummins","year":"1990","unstructured":"Cummins D et al (1990) Acute sensorineural deafness in Lassa fever. JAMA 264:2093\u20132096","journal-title":"JAMA"},{"key":"214_CR39","doi-asserted-by":"publisher","unstructured":"Demby AH et al (2001) Lassa fever in Guinea: II. Distribution and prevalence of Lassa virus infection in small mammals. Vector Borne Zoonotic Dis 1:283\u2013297. https:\/\/doi.org\/10.1089\/15303660160025912","DOI":"10.1089\/15303660160025912"},{"key":"214_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2019.07.015","author":"KA Eberhardt","year":"2019","unstructured":"Eberhardt KA et al (2019) Ribavirin for the treatment of lassa fever: a systematic review and meta-analysis. Int J Infect Dis: IJID: Official Publ Int Soci Infect Dis. https:\/\/doi.org\/10.1016\/j.ijid.2019.07.015","journal-title":"Int J Infect Dis: IJID: Official Publ Int Soci Infect Dis"},{"key":"214_CR41","unstructured":"ECDC (2016) Lassa fever in Nigeria, Benin, Togo, Germany and USA. Eur Centre Dis Prev Control (23 Mar 2016)"},{"key":"214_CR42","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1128\/jcm.01891-10","volume":"49","author":"DU Ehichioya","year":"2011","unstructured":"Ehichioya DU et al (2011) Current molecular epidemiology of Lassa virus in Nigeria. J Clin Microbiol 49:1157\u20131161. https:\/\/doi.org\/10.1128\/jcm.01891-10","journal-title":"J Clin Microbiol"},{"key":"214_CR43","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00929-19","author":"DU Ehichioya","year":"2019","unstructured":"Ehichioya DU et al (2019) Phylogeography of Lassa virus in Nigeria. J Virol. https:\/\/doi.org\/10.1128\/jvi.00929-19","journal-title":"J Virol"},{"key":"214_CR44","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/s0014-5793(03)00160-1","volume":"538","author":"R Eichler","year":"2003","unstructured":"Eichler R, Lenz O, Strecker T, Garten W (2003) Signal peptide of Lassa virus glycoprotein GP-C exhibits an unusual length. FEBS Lett 538:203\u2013206. https:\/\/doi.org\/10.1016\/s0014-5793(03)00160-1","journal-title":"FEBS Lett"},{"key":"214_CR45","doi-asserted-by":"crossref","unstructured":"Enria DA, Barrera Oro JG (2002) Junin virus vaccines. Curr Top Microbiol Immunol 263:239\u2013261","DOI":"10.1007\/978-3-642-56055-2_12"},{"key":"214_CR46","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0166-3542(94)90030-2","volume":"23","author":"DA Enria","year":"1994","unstructured":"Enria DA, Maiztegui JI (1994) Antiviral treatment of Argentine hemorrhagic fever. Antiviral Res 23:23\u201331","journal-title":"Antiviral Res"},{"key":"214_CR47","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.antiviral.2007.10.010","volume":"78","author":"DA Enria","year":"2008","unstructured":"Enria DA, Briggiler AM, Sanchez Z (2008) Treatment of Argentine hemorrhagic fever. Antiviral Res 78:132\u2013139. https:\/\/doi.org\/10.1016\/j.antiviral.2007.10.010","journal-title":"Antiviral Res"},{"key":"214_CR48","unstructured":"Enria DA, Ambrosio AM, Briggiler AM, Feuillade MR, Crivelli E (2010) [Candid#1 vaccine against Argentine hemorrhagic fever produced in Argentina. Immunogenicity and safety]. Medicina 70:215\u2013222"},{"key":"#cr-split#-214_CR49.1","unstructured":"Fabiyi A, Tomori O (1975) Use of the complement fixation"},{"key":"#cr-split#-214_CR49.2","unstructured":"(CF) test in Lassa fever surveillance. Evidence for persistent CF antibodies. Bull World Health Organ 52, 605-608 (1975)"},{"key":"214_CR50","first-page":"23","volume":"9","author":"A Fabiyi","year":"1979","unstructured":"Fabiyi A, Tomori O, Pinneo P (1979) Lassa fever antibodies in hospital personnel in the Plateau State of Nigeria. Niger Med J 9:23\u201325","journal-title":"Niger Med J"},{"key":"214_CR51","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1089\/vbz.2006.0520","volume":"7","author":"E Fichet-Calvet","year":"2007","unstructured":"Fichet-Calvet E et al (2007) Fluctuation of abundance and Lassa virus prevalence in Mastomys natalensis in Guinea, West Africa. Vector Borne Zoonotic Dis 7:119\u2013128. https:\/\/doi.org\/10.1089\/vbz.2006.0520","journal-title":"Vector Borne Zoonotic Dis"},{"key":"214_CR52","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1089\/vbz.2007.0118","volume":"8","author":"E Fichet-Calvet","year":"2008","unstructured":"Fichet-Calvet E, Lecompte E, Koivogui L, Daffis S, ter Meulen J (2008) Reproductive characteristics of Mastomys natalensis and Lassa virus prevalence in Guinea, West Africa. Vector Borne Zoonotic Dis 8:41\u201348. https:\/\/doi.org\/10.1089\/vbz.2007.0118","journal-title":"Vector Borne Zoonotic Dis"},{"key":"214_CR53","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0140-6736(85)90752-4","volume":"2","author":"SP Fisher-Hoch","year":"1985","unstructured":"Fisher-Hoch SP et al (1985) Safe intensive-care management of a severe case of Lassa fever with simple barrier nursing techniques. Lancet 2:1227\u20131229","journal-title":"Lancet"},{"key":"214_CR54","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/infdis\/155.3.465","volume":"155","author":"SP Fisher-Hoch","year":"1987","unstructured":"Fisher-Hoch SP et al (1987) Physiological and immunologic disturbances associated with shock in a primate model of Lassa fever. J Infect Dis 155:465\u2013474. https:\/\/doi.org\/10.1093\/infdis\/155.3.465","journal-title":"J Infect Dis"},{"key":"214_CR55","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1073\/pnas.86.1.317","volume":"86","author":"SP Fisher-Hoch","year":"1989","unstructured":"Fisher-Hoch SP et al (1989) Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein gene. Proc Natl Acad Sci U S A 86:317\u2013321. https:\/\/doi.org\/10.1073\/pnas.86.1.317","journal-title":"Proc Natl Acad Sci U S A"},{"key":"214_CR56","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/bmj.311.7009.857","volume":"311","author":"SP Fisher-Hoch","year":"1995","unstructured":"Fisher-Hoch SP et al (1995) Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. BMJ 311:857\u2013859","journal-title":"BMJ"},{"key":"214_CR57","doi-asserted-by":"crossref","unstructured":"Frame JD, Baldwin JM, Jr, Gocke DJ, Troup JM (1970) Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings. Am J Trop Med Hyg 19:670\u2013676","DOI":"10.4269\/ajtmh.1970.19.670"},{"key":"214_CR58","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0035-9203(79)90218-9","volume":"73","author":"JD Frame","year":"1979","unstructured":"Frame JD, Casals J, Dennis EA (1979) Lassa virus antibodies in hospital personnel in western Liberia. Trans R Soc Trop Med Hyg 73:219\u2013224. https:\/\/doi.org\/10.1016\/0035-9203(79)90218-9","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"214_CR59","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0035-9203(84)90107-X","volume":"78","author":"JD Frame","year":"1984","unstructured":"Frame JD, Verbrugge GP, Gill RG, Pinneo L (1984) The use of Lassa fever convalescent plasma in Nigeria. Trans R Soc Trop Med Hyg 78:319\u2013324","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"214_CR60","doi-asserted-by":"publisher","unstructured":"Fraser DW, Campbell CC, Monath TP, Goff PA, Gregg MB (1974) Lassa fever in the Eastern Province of Sierra Leone, 1970\u20131972. I. Epidemiologic studies. Am J Trop Med Hyg 23, 1131\u20131139. https:\/\/doi.org\/10.4269\/ajtmh.1974.23.1131","DOI":"10.4269\/ajtmh.1974.23.1131"},{"key":"214_CR61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2180-1-1","volume":"1","author":"WR Gallaher","year":"2001","unstructured":"Gallaher WR, DiSimone C, Buchmeier MJ (2001) The viral transmembrane superfamily: possible divergence of Arenavirus and Filovirus glycoproteins from a common RNA virus ancestor. BMC Microbiol 1:1","journal-title":"BMC Microbiol"},{"key":"214_CR62","doi-asserted-by":"publisher","unstructured":"Garry CE, Garry RF (2019) Proteomics computational analyses suggest that the antennavirus glycoprotein complex includes a class I viral fusion protein (alpha-penetrene) with an Internal zinc-binding domain and a stable signal peptide. Viruses 11. https:\/\/doi.org\/10.3390\/v11080750","DOI":"10.3390\/v11080750"},{"key":"214_CR63","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1126\/science.1259657","volume":"345","author":"SK Gire","year":"2014","unstructured":"Gire SK et al (2014) Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science 345:1369\u20131372. https:\/\/doi.org\/10.1126\/science.1259657","journal-title":"Science"},{"key":"214_CR64","doi-asserted-by":"publisher","first-page":"S110","DOI":"10.1093\/infdis\/jiw239","volume":"214","author":"A Goba","year":"2016","unstructured":"Goba A et al (2016) An outbreak of ebola virus disease in the lassa fever zone. J Infect Dis 214:S110\u2013s121. https:\/\/doi.org\/10.1093\/infdis\/jiw239","journal-title":"J Infect Dis"},{"key":"214_CR65","doi-asserted-by":"publisher","DOI":"10.1093\/epirev\/mxz012","author":"D Gouglas","year":"2019","unstructured":"Gouglas D, Christodoulou M, Plotkin SA, Hatchett R (2019) CEPI: driving progress towards epidemic preparedness and response. Epidemiol Rev. https:\/\/doi.org\/10.1093\/epirev\/mxz012","journal-title":"Epidemiol Rev"},{"key":"214_CR66","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2217\/fvl.15.41","volume":"10","author":"JN Hartnett","year":"2015","unstructured":"Hartnett JN et al (2015) Current and emerging strategies for the diagnosis, prevention and treatment of Lassa fever. Future Virol 10:559\u2013584","journal-title":"Future Virol"},{"key":"214_CR67","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.coviro.2018.05.002","volume":"31","author":"KM Hastie","year":"2018","unstructured":"Hastie KM, Saphire EO (2018) Lassa virus glycoprotein: stopping a moving target. Curr Opin Virol 31:52\u201358. https:\/\/doi.org\/10.1016\/j.coviro.2018.05.002","journal-title":"Curr Opin Virol"},{"key":"214_CR68","doi-asserted-by":"publisher","first-page":"19365","DOI":"10.1073\/pnas.1108515108","volume":"108","author":"KM Hastie","year":"2011","unstructured":"Hastie KM et al (2011a) Crystal structure of the Lassa virus nucleoprotein-RNA complex reveals a gating mechanism for RNA binding. Proc Natl Acad Sci U S A 108:19365\u201319370. https:\/\/doi.org\/10.1073\/pnas.1108515108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"214_CR69","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1073\/pnas.1016404108","volume":"108","author":"KM Hastie","year":"2011","unstructured":"Hastie KM, Kimberlin CR, Zandonatti MA, MacRae IJ, Saphire EO (2011b) Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3\u2032 to 5\u2032 exonuclease activity essential for immune suppression. Proc Natl Acad Sci U S A 108:2396\u20132401. https:\/\/doi.org\/10.1073\/pnas.1016404108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"214_CR70","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.coviro.2012.01.003","volume":"2","author":"KM Hastie","year":"2012","unstructured":"Hastie KM, Bale S, Kimberlin CR, Saphire EO (2012a) Hiding the evidence: two strategies for innate immune evasion by hemorrhagic fever viruses. Curr Opin Virol 2:151\u2013156. https:\/\/doi.org\/10.1016\/j.coviro.2012.01.003","journal-title":"Curr Opin Virol"},{"key":"214_CR71","doi-asserted-by":"publisher","first-page":"e44211","DOI":"10.1371\/journal.pone.0044211","volume":"7","author":"KM Hastie","year":"2012","unstructured":"Hastie KM, King LB, Zandonatti MA, Saphire EO (2012b) Structural basis for the dsRNA specificity of the Lassa virus NP exonuclease. PLoS ONE 7:e44211. https:\/\/doi.org\/10.1371\/journal.pone.0044211","journal-title":"PLoS ONE"},{"key":"214_CR72","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1126\/science.aam7260","volume":"356","author":"KM Hastie","year":"2017","unstructured":"Hastie KM et al (2017) Structural basis for antibody-mediated neutralization of Lassa virus. Science 356:923\u2013928. https:\/\/doi.org\/10.1126\/science.aam7260","journal-title":"Science"},{"key":"214_CR73","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.cell.2019.07.020","volume":"178","author":"KM Hastie","year":"2019","unstructured":"Hastie KM et al (2019) Convergent structures illuminate features for germline antibody binding and pan-lassa virus neutralization. Cell 178:1004\u20131015.e1014. https:\/\/doi.org\/10.1016\/j.cell.2019.07.020","journal-title":"Cell"},{"key":"214_CR74","doi-asserted-by":"crossref","unstructured":"Henderson BE, Gary GW, Jr, Kissling RE, Frame JD, Carey DE (1972) Lassa fever. Virological and serological studies. Trans R Soc Trop Med Hyg 66:409\u2013416","DOI":"10.1016\/0035-9203(72)90272-6"},{"key":"214_CR75","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/2049-632x.12171","volume":"71","author":"PB Jahrling","year":"2014","unstructured":"Jahrling PB et al (2014) The NIAID integrated research facility at Frederick, Maryland: a unique international resource to facilitate medical countermeasure development for BSL-4 pathogens. Pathog Dis 71:213\u2013219. https:\/\/doi.org\/10.1111\/2049-632x.12171","journal-title":"Pathog Dis"},{"key":"214_CR76","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1080\/21645515.2019.1616499","volume":"15","author":"J Jiang","year":"2019","unstructured":"Jiang J et al (2019) Immunogenicity of a protective intradermal DNA vaccine against Lassa virus in cynomolgus macaques. Human Vaccines & Immunotherapeutics 15:2066\u20132074. https:\/\/doi.org\/10.1080\/21645515.2019.1616499","journal-title":"Human Vaccines & Immunotherapeutics"},{"key":"214_CR77","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJM199010183231611","volume":"323","author":"KM Johnson","year":"1990","unstructured":"Johnson KM, Monath TP (1990) Imported Lassa fever\u2013reexamining the algorithms. N Engl J Med 323:1139\u20131141","journal-title":"N Engl J Med"},{"key":"214_CR78","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1093\/infdis\/155.3.456","volume":"155","author":"KM Johnson","year":"1987","unstructured":"Johnson KM et al (1987) Clinical virology of Lassa fever in hospitalized patients. J Infect Dis 155:456\u2013464. https:\/\/doi.org\/10.1093\/infdis\/155.3.456","journal-title":"J Infect Dis"},{"key":"214_CR79","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1126\/science.aau9343","volume":"363","author":"LE Kafetzopoulou","year":"2019","unstructured":"Kafetzopoulou LE et al (2019) Metagenomic sequencing at the epicenter of the Nigeria 2018 Lassa fever outbreak. Science 363:74\u201377. https:\/\/doi.org\/10.1126\/science.aau9343","journal-title":"Science"},{"key":"214_CR80","doi-asserted-by":"crossref","first-page":"829","DOI":"10.4269\/ajtmh.1983.32.829","volume":"32","author":"RA Keenlyside","year":"1983","unstructured":"Keenlyside RA et al (1983) Case-control study of Mastomys natalensis and humans in Lassa virus-infected households in Sierra Leone. Am J Trop Med Hyg 32:829\u2013837","journal-title":"Am J Trop Med Hyg"},{"key":"214_CR81","doi-asserted-by":"publisher","first-page":"e548","DOI":"10.1371\/journal.pntd.0000548","volume":"3","author":"S Kerneis","year":"2009","unstructured":"Kerneis S et al (2009) Prevalence and risk factors of Lassa seropositivity in inhabitants of the forest region of Guinea: a cross-sectional study. PLoS Negl Tropical Dis 3:e548. https:\/\/doi.org\/10.1371\/journal.pntd.0000548","journal-title":"PLoS Negl Tropical Dis"},{"key":"214_CR82","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.antiviral.2007.11.003","volume":"78","author":"SH Khan","year":"2008","unstructured":"Khan SH et al (2008) New opportunities for field research on the pathogenesis and treatment of Lassa fever. Antiviral Res 78:103\u2013115. https:\/\/doi.org\/10.1016\/j.antiviral.2007.11.003","journal-title":"Antiviral Res"},{"key":"214_CR83","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/s0140-6736(79)90659-7","volume":"2","author":"MP Kiley","year":"1979","unstructured":"Kiley MP, Lange JV, Johnson KM (1979) Protection of rhesus monkeys from Lassa virus by immunisation with closely related Arenavirus. Lancet 2:738. https:\/\/doi.org\/10.1016\/s0140-6736(79)90659-7","journal-title":"Lancet"},{"key":"214_CR84","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/0042-6822(89)90262-6","volume":"168","author":"LS Klavinskis","year":"1989","unstructured":"Klavinskis LS, Oldstone MB (1989) Lymphocytic choriomeningitis virus selectively alters differentiated but not housekeeping functions: block in expression of growth hormone gene is at the level of transcriptional initiation. Virology 168:232\u2013235. https:\/\/doi.org\/10.1016\/0042-6822(89)90262-6","journal-title":"Virology"},{"key":"214_CR85","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1083\/jcb.200104103","volume":"155","author":"S Kunz","year":"2001","unstructured":"Kunz S, Sevilla N, McGavern DB, Campbell KP, Oldstone MB (2001) Molecular analysis of the interaction of LCMV with its cellular receptor [alpha]-dystroglycan. J Cell Biol 155:301\u2013310. https:\/\/doi.org\/10.1083\/jcb.200104103","journal-title":"J Cell Biol"},{"key":"214_CR86","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.virol.2003.07.002","volume":"316","author":"S Kunz","year":"2003","unstructured":"Kunz S, Campbell KP, Oldstone MB (2003) Alpha-dystroglycan can mediate arenavirus infection in the absence of beta-dystroglycan. Virology 316:213\u2013220. https:\/\/doi.org\/10.1016\/j.virol.2003.07.002","journal-title":"Virology"},{"key":"214_CR87","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.virol.2004.04.044","volume":"325","author":"S Kunz","year":"2004","unstructured":"Kunz S, Calder L, Oldstone MB (2004a) Electron microscopy of an alpha-dystroglycan fragment containing receptor sites for lymphocytic choriomeningitis virus and laminin, and use of the receptoid body as a reagent to neutralize virus. Virology 325:207\u2013215. https:\/\/doi.org\/10.1016\/j.virol.2004.04.044","journal-title":"Virology"},{"key":"214_CR88","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.virol.2004.05.009","volume":"325","author":"S Kunz","year":"2004","unstructured":"Kunz S, Sevilla N, Rojek JM, Oldstone MB (2004b) Use of alternative receptors different than alpha-dystroglycan by selected isolates of lymphocytic choriomeningitis virus. Virology 325:432\u2013445. https:\/\/doi.org\/10.1016\/j.virol.2004.05.009","journal-title":"Virology"},{"key":"214_CR89","doi-asserted-by":"publisher","first-page":"5979","DOI":"10.1128\/jvi.79.10.5979-5987.2005","volume":"79","author":"S Kunz","year":"2005","unstructured":"Kunz S, Rojek JM, Perez M, Spiropoulou CF, Oldstone MB (2005) Characterization of the interaction of lassa fever virus with its cellular receptor alpha-dystroglycan. J Virol 79:5979\u20135987. https:\/\/doi.org\/10.1128\/jvi.79.10.5979-5987.2005","journal-title":"J Virol"},{"key":"214_CR90","doi-asserted-by":"crossref","first-page":"999","DOI":"10.4269\/ajtmh.1985.34.999","volume":"34","author":"JV Lange","year":"1985","unstructured":"Lange JV et al (1985) Kinetic study of platelets and fibrinogen in Lassa virus-infected monkeys and early pathologic events in Mopeia virus-infected monkeys. Am J Trop Med Hyg 34:999\u20131007","journal-title":"Am J Trop Med Hyg"},{"key":"214_CR91","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.3201\/eid1212.060812","volume":"12","author":"E Lecompte","year":"2006","unstructured":"Lecompte E et al (2006) Mastomys natalensis and Lassa fever, West Africa. Emerg Infect Dis 12:1971\u20131974. https:\/\/doi.org\/10.3201\/eid1212.060812","journal-title":"Emerg Infect Dis"},{"key":"214_CR92","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.1128\/jvi.74.8.3470-3477.2000","volume":"74","author":"KJ Lee","year":"2000","unstructured":"Lee KJ, Novella IS, Teng MN, Oldstone MB, de La Torre JC (2000) NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs. J Virol 74:3470\u20133477. https:\/\/doi.org\/10.1128\/jvi.74.8.3470-3477.2000","journal-title":"J Virol"},{"key":"214_CR93","doi-asserted-by":"crossref","unstructured":"Leifer E, Gocke DJ, Bourne H (1970) Lassa fever, a new virus disease of man from West Africa. II. Report of a laboratory-acquired infection treated with plasma from a person recently recovered from the disease. Am J Trop Med Hyg 19:677\u2013679","DOI":"10.4269\/ajtmh.1970.19.677"},{"key":"214_CR94","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/s0140-6736(89)91833-3","volume":"2","author":"G Lloyd","year":"1989","unstructured":"Lloyd G, Barber GN, Clegg JC, Kelly P (1989) Identification of Lassa fever virus infection with recombinant nucleocapsid protein antigen. Lancet 2:1222. https:\/\/doi.org\/10.1016\/s0140-6736(89)91833-3","journal-title":"Lancet"},{"key":"214_CR95","first-page":"207","volume":"65","author":"IS Lukashevich","year":"1985","unstructured":"Lukashevich IS (1985) Lassa virus lethality for inbred mice. Ann Soc Belg Med Trop 65:207\u2013209","journal-title":"Ann Soc Belg Med Trop"},{"key":"214_CR96","unstructured":"Lukashevich IS, Vasiuchkov AD, Mar\u2019iankova RF, Votiakov VI (1982) [Factors affecting plaque formation by Lassa virus in Vero cells]. Vopr Virusol, 57\u201361"},{"key":"214_CR97","first-page":"282","volume":"27","author":"IS Lukashevich","year":"1983","unstructured":"Lukashevich IS, Maryankova RF, Fidarov FM (1983) Reproduction of Lassa virus in different cell cultures. Acta Virol 27:282\u2013285","journal-title":"Acta Virol"},{"key":"214_CR98","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/jmv.1890400308","volume":"40","author":"LS Lukashevich","year":"1993","unstructured":"Lukashevich LS, Clegg JC, Sidibe K (1993) Lassa virus activity in Guinea: distribution of human antiviral antibody defined using enzyme-linked immunosorbent assay with recombinant antigen. J Med Virol 40:210\u2013217","journal-title":"J Med Virol"},{"issue":"Pt 3","key":"214_CR99","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1099\/0022-1317-78-3-547","volume":"78","author":"IS Lukashevich","year":"1997","unstructured":"Lukashevich IS et al (1997) The Lassa fever virus L gene: nucleotide sequence, comparison, and precipitation of a predicted 250\u00a0kDa protein with monospecific antiserum. J Gen Virol 78(Pt 3):547\u2013551. https:\/\/doi.org\/10.1099\/0022-1317-78-3-547","journal-title":"J Gen Virol"},{"key":"214_CR100","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/(SICI)1096-9071(199912)59:4<552::AID-JMV21>3.0.CO;2-A","volume":"59","author":"IS Lukashevich","year":"1999","unstructured":"Lukashevich IS et al (1999) Lassa and Mopeia virus replication in human monocytes\/macrophages and in endothelial cells: different effects on IL-8 and TNF-alpha gene expression. J Med Virol 59:552\u2013560","journal-title":"J Med Virol"},{"key":"214_CR101","doi-asserted-by":"publisher","first-page":"5246","DOI":"10.1016\/j.vaccine.2008.07.057","volume":"26","author":"IS Lukashevich","year":"2008","unstructured":"Lukashevich IS et al (2008) Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates. Vaccine 26:5246\u20135254. https:\/\/doi.org\/10.1016\/j.vaccine.2008.07.057","journal-title":"Vaccine"},{"key":"214_CR102","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1128\/jcm.28.12.2689-2692.1990","volume":"28","author":"K Lunkenheimer","year":"1990","unstructured":"Lunkenheimer K, Hufert FT, Schmitz H (1990) Detection of Lassa virus RNA in specimens from patients with Lassa fever by using the polymerase chain reaction. J Clin Microbiol 28:2689\u20132692","journal-title":"J Clin Microbiol"},{"key":"214_CR103","doi-asserted-by":"publisher","first-page":"e1007439","DOI":"10.1371\/journal.ppat.1007439","volume":"14","author":"IG Madu","year":"2018","unstructured":"Madu IG et al (2018) A potent Lassa virus antiviral targets an arenavirus virulence determinant. PLoS Pathog 14:e1007439. https:\/\/doi.org\/10.1371\/journal.ppat.1007439","journal-title":"PLoS Pathog"},{"key":"214_CR104","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.chom.2015.11.005","volume":"18","author":"S Mahmutovic","year":"2015","unstructured":"Mahmutovic S et al (2015) Molecular basis for antibody-mediated neutralization of new world hemorrhagic fever mammarenaviruses. Cell Host Microbe 18:705\u2013713. https:\/\/doi.org\/10.1016\/j.chom.2015.11.005","journal-title":"Cell Host Microbe"},{"key":"214_CR105","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.3389\/fmicb.2015.01037","volume":"6","author":"JT Manning","year":"2015","unstructured":"Manning JT, Forrester N, Paessler S (2015) Lassa virus isolates from Mali and the Ivory Coast represent an emerging fifth lineage. Front Microbiol 6:1037. https:\/\/doi.org\/10.3389\/fmicb.2015.01037","journal-title":"Front Microbiol"},{"key":"214_CR106","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1186\/preaccept-1698056557139770","volume":"15","author":"CB Matranga","year":"2014","unstructured":"Matranga CB et al (2014) Enhanced methods for unbiased deep sequencing of Lassa and Ebola RNA viruses from clinical and biological samples. Genome Biol 15:519. https:\/\/doi.org\/10.1186\/preaccept-1698056557139770","journal-title":"Genome Biol"},{"key":"214_CR107","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF02122438","volume":"175","author":"JB McCormick","year":"1986","unstructured":"McCormick JB (1986) Clinical, epidemiologic, and therapeutic aspects of Lassa fever. Med Microbiol Immunol (Berl) 175:153\u2013155","journal-title":"Med Microbiol Immunol (Berl)"},{"key":"214_CR108","doi-asserted-by":"crossref","unstructured":"McCormick JB et al (1986) Lassa fever. Effective therapy with ribavirin. N Engl J Med 314:20\u201326","DOI":"10.1056\/NEJM198601023140104"},{"key":"214_CR109","unstructured":"McCormick JB, Fisher-Hoch S (1996) Level 4 Virus Hunters of the CDC (379). Turner Publications"},{"key":"214_CR110","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/infdis\/155.3.445","volume":"155","author":"JB McCormick","year":"1987","unstructured":"McCormick JB et al (1987a) A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis 155:445\u2013455","journal-title":"J Infect Dis"},{"key":"214_CR111","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1093\/infdis\/155.3.437","volume":"155","author":"JB McCormick","year":"1987","unstructured":"McCormick JB, Webb PA, Krebs JW, Johnson KM, Smith ES (1987b) A prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis 155:437\u2013444. https:\/\/doi.org\/10.1093\/infdis\/155.3.437","journal-title":"J Infect Dis"},{"key":"214_CR112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jmv.1890370102","volume":"37","author":"JB McCormick","year":"1992","unstructured":"McCormick JB, Mitchell SW, Kiley MP, Ruo S, Fisher-Hoch SP (1992) Inactivated Lassa virus elicits a non protective immune response in rhesus monkeys. J Med Virol 37:1\u20137","journal-title":"J Med Virol"},{"key":"214_CR113","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.antiviral.2018.09.009","volume":"159","author":"MS Mehand","year":"2018","unstructured":"Mehand MS, Al-Shorbaji F, Millett P, Murgue B (2018) The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts. Antiviral Res 159:63\u201367. https:\/\/doi.org\/10.1016\/j.antiviral.2018.09.009","journal-title":"Antiviral Res"},{"key":"214_CR114","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/nm.4396","volume":"23","author":"CE Mire","year":"2017","unstructured":"Mire CE et al (2017) Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever. Nat Med 23:1146\u20131149. https:\/\/doi.org\/10.1038\/nm.4396","journal-title":"Nat Med"},{"key":"214_CR115","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.coviro.2019.06.005","volume":"37","author":"TP Monath","year":"2019","unstructured":"Monath TP (2019) A short history of Lassa fever: the first 10\u201315\u00a0years after discovery. Curr Opin Virol 37:77\u201383. https:\/\/doi.org\/10.1016\/j.coviro.2019.06.005","journal-title":"Curr Opin Virol"},{"key":"214_CR116","doi-asserted-by":"publisher","first-page":"773","DOI":"10.4269\/ajtmh.1973.22.773","volume":"22","author":"TP Monath","year":"1973","unstructured":"Monath TP et al (1973) A hospital epidemic of Lassa fever in Zorzor, Liberia, March\u2013April 1972. Am J Trop Med Hyg 22:773\u2013779. https:\/\/doi.org\/10.4269\/ajtmh.1973.22.773","journal-title":"Am J Trop Med Hyg"},{"key":"214_CR117","doi-asserted-by":"publisher","unstructured":"Monath TP, Maher M, Casals J, Kissling RE, Cacciapuoti A (1974a) Lassa fever in the Eastern Province of Sierra Leone, 1970\u20131972. II. Clinical observations and virological studies on selected hospital cases. Am J Trop Med Hyg 23:1140\u20131149. https:\/\/doi.org\/10.4269\/ajtmh.1974.23.1140","DOI":"10.4269\/ajtmh.1974.23.1140"},{"key":"214_CR118","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1126\/science.185.4147.263","volume":"185","author":"TP Monath","year":"1974","unstructured":"Monath TP, Newhouse VF, Kemp GE, Setzer HW, Cacciapuoti A (1974b) Lassa virus isolation from Mastomys natalensis rodents during an epidemic in Sierra Leone. Science 185:263\u2013265. https:\/\/doi.org\/10.1126\/science.185.4147.263","journal-title":"Science"},{"key":"214_CR119","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0042-6822(89)90525-4","volume":"171","author":"HG Morrison","year":"1989","unstructured":"Morrison HG et al (1989) Protection of guinea pigs from Lassa fever by vaccinia virus recombinants expressing the nucleoprotein or the envelope glycoproteins of Lassa virus. Virology 171:179\u2013188. https:\/\/doi.org\/10.1016\/0042-6822(89)90525-4","journal-title":"Virology"},{"key":"214_CR120","doi-asserted-by":"publisher","unstructured":"Okogbenin S et al (2019) Retrospective cohort study of lassa fever in pregnancy, Southern Nigeria. Emerg Infect Dis 25, https:\/\/doi.org\/10.3201\/eid2508.181299","DOI":"10.3201\/eid2508.181299"},{"key":"214_CR121","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/s1473-3099(18)30121-x","volume":"18","author":"P Okokhere","year":"2018","unstructured":"Okokhere P et al (2018) Clinical and laboratory predictors of Lassa fever outcome in a dedicated treatment facility in Nigeria: a retrospective, observational cohort study. Lancet Infect Dis 18:684\u2013695. https:\/\/doi.org\/10.1016\/s1473-3099(18)30121-x","journal-title":"Lancet Infect Dis"},{"key":"214_CR122","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3201\/eid2204.150155","volume":"22","author":"A Olayemi","year":"2016","unstructured":"Olayemi A et al (2016a) Arenavirus diversity and phylogeography of Mastomys natalensis rodents, Nigeria. Emerg Infect Dis 22:694\u2013697. https:\/\/doi.org\/10.3201\/eid2204.150155","journal-title":"Emerg Infect Dis"},{"key":"214_CR123","doi-asserted-by":"publisher","first-page":"25280","DOI":"10.1038\/srep25280","volume":"6","author":"A Olayemi","year":"2016","unstructured":"Olayemi A et al (2016b) New hosts of the Lassa virus. Sci Rep 6:25280. https:\/\/doi.org\/10.1038\/srep25280","journal-title":"Sci Rep"},{"key":"214_CR124","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0042-6822(70)90330-2","volume":"42","author":"MB Oldstone","year":"1970","unstructured":"Oldstone MB, Dixon FJ (1970) Tissue injury in lymphocytic choriomeningitis viral infection: virus-induced immunologically specific release of a cytotoxic factor from immune lymphoid cells. Virology 42:805\u2013813","journal-title":"Virology"},{"key":"214_CR125","doi-asserted-by":"publisher","unstructured":"Oldstone MB, Dixon FJ (1972) Disease accompanying in utero viral infection. The role of maternal antibody in tissue injury after transplacental infection with lymphocytic choriomeningitis virus. J Exp Med 135:827\u2013838. https:\/\/doi.org\/10.1084\/jem.135.4.827","DOI":"10.1084\/jem.135.4.827"},{"key":"214_CR126","doi-asserted-by":"publisher","unstructured":"Oldstone MB, Dixon FJ, Mitchell GF, McDevitt HO (1973) Histocompatibility-linked genetic control of disease susceptibility. Murine lymphocytic choriomeningitis virus infection. J Exp Med 137:1201\u20131212. https:\/\/doi.org\/10.1084\/jem.137.5.1201","DOI":"10.1084\/jem.137.5.1201"},{"key":"214_CR127","doi-asserted-by":"crossref","first-page":"831","DOI":"10.4049\/jimmunol.124.2.831","volume":"124","author":"MB Oldstone","year":"1980","unstructured":"Oldstone MB, Buchmeier MJ, Doyle MV, Tishon A (1980) Virus-induced immune complex disease: specific anti-viral antibody and C1q binding material in the circulation during persistent lymphocytic choriomeningitis virus infection. J Immunol 124:831\u2013838","journal-title":"J Immunol"},{"key":"214_CR128","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1093\/oxfordjournals.bmb.a072029","volume":"41","author":"MB Oldstone","year":"1985","unstructured":"Oldstone MB et al (1985) Virus and immune responses: lymphocytic choriomeningitis virus as a prototype model of viral pathogenesis. Br Med Bull 41:70\u201374. https:\/\/doi.org\/10.1093\/oxfordjournals.bmb.a072029","journal-title":"Br Med Bull"},{"issue":"Pt 4","key":"214_CR129","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1099\/0022-1317-71-4-785","volume":"71","author":"MB Oldstone","year":"1990","unstructured":"Oldstone MB et al (1990) Cytotoxic T lymphocytes do not control lymphocytic choriomeningitis virus infection of BB diabetes-prone rats. J Gen Virol 71(Pt 4):785\u2013791. https:\/\/doi.org\/10.1099\/0022-1317-71-4-785","journal-title":"J Gen Virol"},{"key":"214_CR130","doi-asserted-by":"publisher","first-page":"e0006971","DOI":"10.1371\/journal.pntd.0006971","volume":"12","author":"OK Oloniniyi","year":"2018","unstructured":"Oloniniyi OK et al (2018) Genetic characterization of Lassa virus strains isolated from 2012 to 2016 in southeastern Nigeria. PLoS Negl Tropical Dis 12:e0006971. https:\/\/doi.org\/10.1371\/journal.pntd.0006971","journal-title":"PLoS Negl Tropical Dis"},{"key":"214_CR131","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.3201\/eid1110.041343","volume":"11","author":"SA Omilabu","year":"2005","unstructured":"Omilabu SA et al (2005) Lassa fever, Nigeria, 2003 and 2004. Emerg Infect Dis 11:1642\u20131644. https:\/\/doi.org\/10.3201\/eid1110.041343","journal-title":"Emerg Infect Dis"},{"key":"214_CR132","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41586-020-2114-2","volume":"579","author":"R Peng","year":"2020","unstructured":"Peng R et al (2020) Structural insight into arenavirus replication machinery. Nature 579:615\u2013619. https:\/\/doi.org\/10.1038\/s41586-020-2114-2","journal-title":"Nature"},{"key":"214_CR133","unstructured":"Petkevich AS, Sabynin VM, Lukashevich IS, Galegov GA, Votiakov VI (1981) [Effect of ribovirin (virazole) on arenavirus reproduction in cell cultures]. Vopr Virusol 244\u2013245"},{"key":"214_CR134","first-page":"1352","volume":"71","author":"L Pinneo","year":"1971","unstructured":"Pinneo L, Pinneo R (1971) Mystery virus from Lassa. Am J Nurs 71:1352\u20131355","journal-title":"Am J Nurs"},{"key":"214_CR135","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/bmj.297.6648.584","volume":"297","author":"ME Price","year":"1988","unstructured":"Price ME, Fisher-Hoch SP, Craven RB, McCormick JB (1988) A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy. BMJ 297:584\u2013587","journal-title":"BMJ"},{"key":"214_CR136","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1128\/jvi.55.3.704-709.1985","volume":"55","author":"Y Riviere","year":"1985","unstructured":"Riviere Y, Ahmed R, Southern PJ, Buchmeier MJ, Oldstone MB (1985) Genetic mapping of lymphocytic choriomeningitis virus pathogenicity: virulence in guinea pigs is associated with the L RNA segment. J Virol 55:704\u2013709","journal-title":"J Virol"},{"key":"214_CR137","doi-asserted-by":"crossref","unstructured":"Riviere Y, Southern PJ, Ahmed R, Oldstone MB (1986) Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. V. Recognition is restricted to gene products encoded by the viral S RNA segment. J Immunol 136:304\u2013307","DOI":"10.4049\/jimmunol.136.1.304"},{"key":"214_CR138","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1365-2141.1989.tb00245.x","volume":"73","author":"PJ Roberts","year":"1989","unstructured":"Roberts PJ et al (1989) Plasma from patients with severe Lassa fever profoundly modulates f-met-leu-phe induced superoxide generation in neutrophils. Br J Haematol 73:152\u2013157","journal-title":"Br J Haematol"},{"key":"214_CR139","doi-asserted-by":"publisher","first-page":"11544","DOI":"10.1038\/ncomms11544","volume":"7","author":"JE Robinson","year":"2016","unstructured":"Robinson JE et al (2016) Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits. Nat Commun 7:11544. https:\/\/doi.org\/10.1038\/ncomms11544","journal-title":"Nat Commun"},{"key":"214_CR140","first-page":"197","volume":"2","author":"JR Rose","year":"1956","unstructured":"Rose JR (1956) A new clinical entity? Lancet 2:197","journal-title":"Lancet"},{"key":"214_CR141","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1001\/jama.1990.03450160089037","volume":"264","author":"LP Rybak","year":"1990","unstructured":"Rybak LP (1990) Deafness associated with Lassa fever. Jama 264:2119","journal-title":"Jama"},{"key":"214_CR142","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/s0140-6736(14)61346-5","volume":"384","author":"TW Ryschon","year":"2014","unstructured":"Ryschon TW (2014) Ebola control measures and inadequate responses. Lancet 384:1181\u20131182. https:\/\/doi.org\/10.1016\/s0140-6736(14)61346-5","journal-title":"Lancet"},{"key":"214_CR143","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1126\/science.1124309","volume":"312","author":"PC Sabeti","year":"2006","unstructured":"Sabeti PC et al (2006) Positive natural selection in the human lineage. Science 312:1614\u20131620. https:\/\/doi.org\/10.1126\/science.1124309","journal-title":"Science"},{"key":"214_CR144","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/nature06250","volume":"449","author":"PC Sabeti","year":"2007","unstructured":"Sabeti PC et al (2007) Genome-wide detection and characterization of positive selection in human populations. Nature 449:913\u2013918. https:\/\/doi.org\/10.1038\/nature06250","journal-title":"Nature"},{"key":"214_CR145","doi-asserted-by":"publisher","first-page":"e2582","DOI":"10.1371\/journal.pntd.0002582","volume":"7","author":"D Safronetz","year":"2013","unstructured":"Safronetz D et al (2013) Geographic distribution and genetic characterization of Lassa virus in sub-Saharan Mali. PLoS Neg Trop Dis 7:e2582. https:\/\/doi.org\/10.1371\/journal.pntd.0002582","journal-title":"PLoS Neg Trop Dis"},{"key":"214_CR146","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1128\/jvi.65.4.1863-1869.1991","volume":"65","author":"M Salvato","year":"1991","unstructured":"Salvato M, Borrow P, Shimomaye E, Oldstone MB (1991) Molecular basis of viral persistence: a single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-lymphocyte response and establishment of persistence. J Virol 65:1863\u20131869","journal-title":"J Virol"},{"key":"214_CR147","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1056\/NEJMoa1411680","volume":"371","author":"JS Schieffelin","year":"2014","unstructured":"Schieffelin JS et al (2014) Clinical illness and outcomes in patients with Ebola in sierra leone. N Engl J Med 371:2092\u20132100. https:\/\/doi.org\/10.1056\/NEJMoa1411680","journal-title":"N Engl J Med"},{"key":"214_CR148","first-page":"67","volume":"11","author":"H Schmitz","year":"1996","unstructured":"Schmitz H, Emmerich P, ter Meulen J (1996) Imported tropical virus infections in Germany. Arch Virol Suppl 11:67\u201374","journal-title":"Arch Virol Suppl"},{"key":"214_CR149","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1286-4579(01)01508-8","volume":"4","author":"H Schmitz","year":"2002","unstructured":"Schmitz H et al (2002) Monitoring of clinical and laboratory data in two cases of imported Lassa fever. Microbes Infect 4:43\u201350","journal-title":"Microbes Infect"},{"key":"214_CR150","doi-asserted-by":"publisher","first-page":"e2748","DOI":"10.1371\/journal.pntd.0002748","volume":"8","author":"JG Shaffer","year":"2014","unstructured":"Shaffer JG et al (2014) Lassa fever in post-conflict sierra leone. PLoS Negl Tropical Dis 8:e2748. https:\/\/doi.org\/10.1371\/journal.pntd.0002748","journal-title":"PLoS Negl Tropical Dis"},{"key":"214_CR151","unstructured":"Siddle KJ et al (2018a) Genomic analysis of Lassa virus, 2018 Nigeria. NEJM accepted"},{"key":"214_CR152","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1056\/NEJMoa1804498","volume":"379","author":"KJ Siddle","year":"2018","unstructured":"Siddle KJ et al (2018b) Genomic analysis of lassa virus during an increase in cases in Nigeria in 2018. N Engl J Med 379:1745\u20131753. https:\/\/doi.org\/10.1056\/NEJMoa1804498","journal-title":"N Engl J Med"},{"key":"214_CR153","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1128\/jvi.75.1.448-457.2001","volume":"75","author":"SC Smelt","year":"2001","unstructured":"Smelt SC et al (2001) Differences in affinity of binding of lymphocytic choriomeningitis virus strains to the cellular receptor alpha-dystroglycan correlate with viral tropism and disease kinetics. J Virol 75:448\u2013457. https:\/\/doi.org\/10.1128\/jvi.75.1.448-457.2001","journal-title":"J Virol"},{"key":"214_CR154","first-page":"20","volume":"9","author":"EA Smith","year":"1979","unstructured":"Smith EA, Fabiyi A, Kuteyi OE, Tomori O (1979) Epidemiological aspect of the 1976 Pankshin Lassa fever outbreak. Niger Med J 9:20\u201322","journal-title":"Niger Med J"},{"key":"214_CR155","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0042-6822(87)90323-0","volume":"157","author":"PJ Southern","year":"1987","unstructured":"Southern PJ et al (1987) Molecular characterization of the genomic S RNA segment from lymphocytic choriomeningitis virus. Virology 157:145\u2013155. https:\/\/doi.org\/10.1016\/0042-6822(87)90323-0","journal-title":"Virology"},{"key":"214_CR156","doi-asserted-by":"publisher","unstructured":"Speir RW, Wood O, Liebhaber H, Buckley SM (1970) Lassa fever, a new virus disease of man from West Africa. IV. Electron microscopy of Vero cell cultures infected with Lassa virus. Am J Trop Med Hyg 19:692\u2013694. https:\/\/doi.org\/10.4269\/ajtmh.1970.19.692","DOI":"10.4269\/ajtmh.1970.19.692"},{"key":"214_CR157","doi-asserted-by":"publisher","first-page":"5140","DOI":"10.1128\/jvi.76.10.5140-5146.2002","volume":"76","author":"CF Spiropoulou","year":"2002","unstructured":"Spiropoulou CF, Kunz S, Rollin PE, Campbell KP, Oldstone MB (2002) New World arenavirus clade C, but not clade A and B viruses, utilizes alpha-dystroglycan as its major receptor. J Virol 76:5140\u20135146. https:\/\/doi.org\/10.1128\/jvi.76.10.5140-5146.2002","journal-title":"J Virol"},{"key":"214_CR158","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0140-6736(79)90790-6","volume":"1","author":"EL Stephen","year":"1979","unstructured":"Stephen EL, Jahrling PB (1979) Experimental Lassa fever virus infection successfully treated with ribavirin. Lancet 1:268\u2013269","journal-title":"Lancet"},{"key":"214_CR159","doi-asserted-by":"publisher","first-page":"10700","DOI":"10.1128\/jvi.77.19.10700-10705.2003","volume":"77","author":"T Strecker","year":"2003","unstructured":"Strecker T et al (2003) Lassa virus Z protein is a matrix protein and sufficient for the release of virus-like particles [corrected]. J Virol 77:10700\u201310705. https:\/\/doi.org\/10.1128\/jvi.77.19.10700-10705.2003","journal-title":"J Virol"},{"key":"214_CR160","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1073\/pnas.1019304108","volume":"108","author":"BM Sullivan","year":"2011","unstructured":"Sullivan BM et al (2011) Point mutation in the glycoprotein of lymphocytic choriomeningitis virus is necessary for receptor binding, dendritic cell infection, and long-term persistence. Proc Natl Acad Sci U S A 108:2969\u20132974. https:\/\/doi.org\/10.1073\/pnas.1019304108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"214_CR161","doi-asserted-by":"publisher","first-page":"e1008352","DOI":"10.1371\/journal.ppat.1008352","volume":"16","author":"BM Sullivan","year":"2020","unstructured":"Sullivan BM et al (2020) High crossreactivity of human T cell responses between Lassa virus lineages. PLoS Pathog 16:e1008352. https:\/\/doi.org\/10.1371\/journal.ppat.1008352","journal-title":"PLoS Pathog"},{"key":"214_CR162","doi-asserted-by":"crossref","first-page":"8438","DOI":"10.1128\/jvi.70.12.8438-8443.1996","volume":"70","author":"MN Teng","year":"1996","unstructured":"Teng MN, Borrow P, Oldstone MB, de la Torre JC (1996) A single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with the ability to cause growth hormone deficiency syndrome. J Virol 70:8438\u20138443","journal-title":"J Virol"},{"key":"214_CR163","doi-asserted-by":"crossref","unstructured":"Tishon A, Southern PJ, Oldstone MB (1988) Virus-lymphocyte interactions. II. Expression of viral sequences during the course of persistent lymphocytic choriomeningitis virus infection and their localization to the L3T4 lymphocyte subset. J Immunol 140:1280\u20131284","DOI":"10.4049\/jimmunol.140.4.1280"},{"key":"214_CR164","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1006\/viro.1993.1613","volume":"197","author":"A Tishon","year":"1993","unstructured":"Tishon A, Eddleston M, de la Torre JC, Oldstone MB (1993) Cytotoxic T lymphocytes cleanse viral gene products from individually infected neurons and lymphocytes in mice persistently infected with lymphocytic choriomeningitis virus. Virology 197:463\u2013467. https:\/\/doi.org\/10.1006\/viro.1993.1613","journal-title":"Virology"},{"key":"214_CR165","first-page":"17","volume":"9","author":"O Tomori","year":"1979","unstructured":"Tomori O, Fabiyi A (1979) Lassa fever virus: properties and characteristics. Niger Med J 9:17\u201319","journal-title":"Niger Med J"},{"key":"214_CR166","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/jmv.1890220110","volume":"22","author":"O Tomori","year":"1987","unstructured":"Tomori O, Johnson KM, Kiley MP, Elliott LH (1987) Standardization of a plaque assay for Lassa virus. J Med Virol 22:77\u201389","journal-title":"J Med Virol"},{"key":"214_CR167","doi-asserted-by":"publisher","first-page":"407","DOI":"10.4269\/ajtmh.1988.38.407","volume":"38","author":"O Tomori","year":"1988","unstructured":"Tomori O, Fabiyi A, Sorungbe A, Smith A, McCormick JB (1988) Viral hemorrhagic fever antibodies in Nigerian populations. Am J Trop Med Hyg 38:407\u2013410. https:\/\/doi.org\/10.4269\/ajtmh.1988.38.407","journal-title":"Am J Trop Med Hyg"},{"issue":"Suppl 1","key":"214_CR168","doi-asserted-by":"publisher","first-page":"S98","DOI":"10.1086\/514307","volume":"179","author":"O Tomori","year":"1999","unstructured":"Tomori O et al (1999) Serologic survey among hospital and health center workers during the Ebola hemorrhagic fever outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 179(Suppl 1):S98\u2013101. https:\/\/doi.org\/10.1086\/514307","journal-title":"J Infect Dis"},{"key":"214_CR169","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4269\/ajtmh.1993.49.214","volume":"49","author":"SG Trappier","year":"1993","unstructured":"Trappier SG et al (1993) Evaluation of the polymerase chain reaction for diagnosis of Lassa virus infection. Am J Trop Med Hyg 49:214\u2013221","journal-title":"Am J Trop Med Hyg"},{"key":"214_CR170","doi-asserted-by":"crossref","unstructured":"Troup JM, White HA, Fom AL, Carey DE (1970) An outbreak of Lassa fever on the Jos plateau, Nigeria, in January-February 1970. A preliminary report. Am J Trop Med Hyg 19:695\u2013696","DOI":"10.4269\/ajtmh.1970.19.695"},{"key":"214_CR171","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF02122424","volume":"175","author":"V Valsamakis","year":"1986","unstructured":"Valsamakis V et al (1986) Dissecting the molecular anatomy of persistent infection with lymphocytic choriomeningitis virus. Med Microbiol Immunol 175:97\u201399","journal-title":"Med Microbiol Immunol"},{"key":"214_CR172","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.virol.2003.09.009","volume":"318","author":"S Vieth","year":"2004","unstructured":"Vieth S, Torda AE, Asper M, Schmitz H, Gunther S (2004) Sequence analysis of L RNA of Lassa virus. Virology 318:153\u2013168. https:\/\/doi.org\/10.1016\/j.virol.2003.09.009","journal-title":"Virology"},{"key":"214_CR173","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/infdis\/146.3.360","volume":"146","author":"DH Walker","year":"1982","unstructured":"Walker DH et al (1982a) Experimental infection of rhesus monkeys with Lassa virus and a closely related arenavirus, Mozambique virus. J Infect Dis 146:360\u2013368","journal-title":"J Infect Dis"},{"key":"214_CR174","first-page":"349","volume":"107","author":"DH Walker","year":"1982","unstructured":"Walker DH et al (1982b) Pathologic and virologic study of fatal Lassa fever in man. Am J Pathol 107:349\u2013356","journal-title":"Am J Pathol"},{"key":"214_CR175","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0140-6736(12)61871-6","volume":"380","author":"GM Watts","year":"2013","unstructured":"Watts GM (2013) Lily Lyman Pinneo. The Lancet 380:1552","journal-title":"The Lancet"},{"key":"214_CR176","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0035-9203(86)90147-1","volume":"80","author":"PA Webb","year":"1986","unstructured":"Webb PA et al (1986) Lassa fever in children in Sierra Leone, West Africa. Trans R Soc Trop Med Hyg 80:577\u2013582","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"214_CR177","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1084\/jem.145.6.1449","volume":"145","author":"RM Welsh","year":"1977","unstructured":"Welsh RM, Oldstone MB (1977) Inhibition of immunologic injury of cultured cells infected with lymphocytic choriomeningitis virus: role of defective interfering virus in regulating viral antigenic expression. J Exp Med 145:1449\u20131468. https:\/\/doi.org\/10.1084\/jem.145.6.1449","journal-title":"J Exp Med"},{"key":"214_CR178","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/infdis\/136.3.391","volume":"136","author":"RM Welsh","year":"1977","unstructured":"Welsh RM, Lampert PW, Oldstone MB (1977) Prevention of virus-induced cerebellar diseases by defective-interfering lymphocytic choriomeningitis virus. J Infect Dis 136:391\u2013399. https:\/\/doi.org\/10.1093\/infdis\/136.3.391","journal-title":"J Infect Dis"},{"key":"214_CR179","doi-asserted-by":"crossref","unstructured":"White HA (1972) Lassa fever. A study of 23 hospital cases. Trans R Soc Trop Med Hyg 66:390\u2013401","DOI":"10.1016\/0035-9203(72)90269-6"},{"key":"214_CR180","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3201\/eid2403.171905","volume":"24","author":"SLM Whitmer","year":"2018","unstructured":"Whitmer SLM et al (2018) New Lineage of Lassa Virus, Togo, 2016. Emerg Infect Dis 24:599\u2013602. https:\/\/doi.org\/10.3201\/eid2403.171905","journal-title":"Emerg Infect Dis"},{"key":"214_CR181","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/0042-6822(88)90471-0","volume":"162","author":"JL Whitton","year":"1988","unstructured":"Whitton JL, Southern PJ, Oldstone MB (1988) Analyses of the cytotoxic T lymphocyte responses to glycoprotein and nucleoprotein components of lymphocytic choriomeningitis virus. Virology 162:321\u2013327. https:\/\/doi.org\/10.1016\/0042-6822(88)90471-0","journal-title":"Virology"},{"key":"214_CR182","unstructured":"WHO (2017) Lassa Fever\u2014Benin, Togo and Burkina Faso. Disease outbreak news, 10 Mar 2017"},{"key":"214_CR183","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(19)30486-4","author":"MR Wiley","year":"2019","unstructured":"Wiley MR et al (2019) Lassa virus circulating in Liberia: a retrospective genomic characterisation. The Lancet. Infect Dis. https:\/\/doi.org\/10.1016\/s1473-3099(19)30486-4","journal-title":"The Lancet. Infect Dis"},{"key":"214_CR184","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0140-6736(04)16324-1","volume":"363","author":"P Wright","year":"2004","unstructured":"Wright P (2004) Aniru Conteh. Lancet 363:1831","journal-title":"Lancet"},{"key":"214_CR185","first-page":"631","volume":"57","author":"H Wulff","year":"1979","unstructured":"Wulff H, Johnson KM (1979) Immunoglobulin M and G responses measured by immunofluorescence in patients with Lassa or Marburg virus infections. Bull World Health Organ 57:631\u2013635","journal-title":"Bull World Health Organ"},{"key":"214_CR186","doi-asserted-by":"publisher","unstructured":"Yadouleton A et al (2019) Lassa virus in Pygmy Mice, Benin, West Africa, 2016\u20132017. Emerg Infect Dis 25 https:\/\/doi.org\/10.3201\/eid2510.180523","DOI":"10.3201\/eid2510.180523"},{"key":"214_CR187","doi-asserted-by":"publisher","first-page":"7775","DOI":"10.1128\/jvi.00642-06","volume":"80","author":"J York","year":"2006","unstructured":"York J, Nunberg JH (2006) Role of the stable signal peptide of Junin arenavirus envelope glycoprotein in pH-dependent membrane fusion. J Virol 80:7775\u20137780. https:\/\/doi.org\/10.1128\/jvi.00642-06","journal-title":"J Virol"},{"key":"214_CR188","doi-asserted-by":"publisher","first-page":"13385","DOI":"10.1128\/jvi.01785-07","volume":"81","author":"J York","year":"2007","unstructured":"York J, Nunberg JH (2007) A novel zinc-binding domain is essential for formation of the functional Junin virus envelope glycoprotein complex. J Virol 81:13385\u201313391. https:\/\/doi.org\/10.1128\/jvi.01785-07","journal-title":"J Virol"},{"key":"214_CR189","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/978-1-4939-6981-4_10","volume":"1604","author":"J York","year":"2018","unstructured":"York J, Nunberg JH (2018) A cell-cell fusion assay to assess arenavirus envelope glycoprotein membrane-fusion activity. Methods Mol Biol 1604:157\u2013167. https:\/\/doi.org\/10.1007\/978-1-4939-6981-4_10","journal-title":"Methods Mol Biol"},{"key":"214_CR190","doi-asserted-by":"publisher","first-page":"10783","DOI":"10.1128\/jvi.78.19.10783-10792.2004","volume":"78","author":"J York","year":"2004","unstructured":"York J, Romanowski V, Lu M, Nunberg JH (2004) The signal peptide of the Junin arenavirus envelope glycoprotein is myristoylated and forms an essential subunit of the mature G1\u2013G2 complex. J Virol 78:10783\u201310792. https:\/\/doi.org\/10.1128\/jvi.78.19.10783-10792.2004","journal-title":"J Virol"},{"key":"214_CR191","doi-asserted-by":"publisher","first-page":"10932","DOI":"10.1128\/jvi.01140-08","volume":"82","author":"J York","year":"2008","unstructured":"York J, Dai D, Amberg SM, Nunberg JH (2008) pH-induced activation of arenavirus membrane fusion is antagonized by small-molecule inhibitors. J Virol 82:10932\u201310939. https:\/\/doi.org\/10.1128\/jvi.01140-08","journal-title":"J Virol"},{"key":"214_CR192","doi-asserted-by":"publisher","first-page":"6119","DOI":"10.1128\/jvi.02700-09","volume":"84","author":"J York","year":"2010","unstructured":"York J et al (2010) An antibody directed against the fusion peptide of Junin virus envelope glycoprotein GPC inhibits pH-induced membrane fusion. J Virol 84:6119\u20136129. https:\/\/doi.org\/10.1128\/jvi.02700-09","journal-title":"J Virol"}],"container-title":["Current Topics in Microbiology and Immunology","Lassa Fever: Epidemiology, Immunology, Diagnostics, and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/82_2020_214","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T08:04:59Z","timestamp":1689581099000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/82_2020_214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9783031358067","9783031358074"],"references-count":193,"URL":"https:\/\/doi.org\/10.1007\/82_2020_214","relation":{},"ISSN":["0070-217X","2196-9965"],"issn-type":[{"value":"0070-217X","type":"print"},{"value":"2196-9965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"27 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}